Results 71 to 80 of about 949 (140)

Expression, purification, and characterization of transmembrane protein homogentisate solanesyltransferase. [PDF]

Appl Microbiol Biotechnol
Xiao H, Mei LC, Lin HY, Chen Z, Yu XH, Yang J, Tong Q, Yang GF.   +7 more
europepmc   +1 more source

Synthesis of Novel Bioactive Lipophilic Hydroxyalkyl Esters and Diesters Based on Hydroxyphenylacetic Acids. [PDF]

Molecules
Fochetti A, Villanova N, Lombardi A, Lelli V, Gazzilli Y, Timperio AM, Fabrizi G, Bernini R.   +7 more
europepmc   +1 more source

BL-918 activates PINK1/Parkin signaling pathway to ameliorate the progression of Parkinson's disease. [PDF]

J Biol Chem
Wang Y, Luo S, Su H, Wang Z, Chu L, Zhang C.   +5 more
europepmc   +1 more source

Intestinal Microbiome Metabolism of Cranberry (Vaccinium macrocarpon) Proanthocyanidin Dimers, but Not Trimers, Is Altered by Dysbiosis in Ulcerative Colitis Ex Vivo. [PDF]

J Agric Food Chem
Diaz MS, Mertens-Talcott SU, Talcott ST.
europepmc   +1 more source

The mGluR5-mediated Arc activation protects against experimental traumatic brain injury in rats. [PDF]

CNS Neurosci Ther
Chen T, Li YF, Ren X, Wang YH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bioproduction of Natural Phenethyl Acetate, Phenylacetic Acid, Ethyl Phenylacetate, and Phenethyl Phenylacetate from Renewable Feedstock

ChemSusChem, 2022
AbstractNatural phenethyl acetate (PEA), phenylacetic acid (PAA), ethyl phenylacetate (Et‐PA), and phenethyl phenylacetate (PE‐PA) are highly desirable aroma chemicals, but with limited availability and high price. Here, green, sustainable, and efficient bioproduction of these chemicals as natural products from renewable feedstocks was developed.
Balaji Sundara Sekar, Xirui Li, Zhi Li
openaire   +2 more sources

Ornithine phenylacetate revisited

Metabolic Brain Disease, 2013
In patients with liver failure hyperammonemia is associated with the development of hepatic encephalopathy (HE) and immune impairment. Treatment of hyperammonemia is an unmet clinical need. Ornithine phenylacetate (OP) is a novel drug that is targeted at reducing ammonia concentration in patients with liver disease and therefore a potential treatment ...
Maria, Jover-Cobos, Lorette, Noiret, Yalda, Sharifi, Rajiv, Jalan   +3 more
openaire   +2 more sources

VULNERABILITY OF THE IMMATURE BRAIN TO PHENYLACETATE INTOXICATION: TISSUE PERMEABILITY TO PHENYLACETATE

Journal of Neurochemistry, 1979
AbstractIn the rat phenylacetate readily penetrates into such tissues as brain, eyes, heart, kidneys, and liver. One hour after the subcutaneous injection of sodium phenylacetate into rats ranging in age from 1 to 65 days, the ratios of the concentrations (μmolig) in blood/tissue were approx 1:1 in all of these tissues with the exception of the brain ...
Y H, Loo, T, Fulton, H M, Wisniewski
openaire   +2 more sources

Enzymatic conversion of phenylpyruvate to phenylacetate

Biochimica et Biophysica Acta (BBA) - General Subjects, 1968
Using Acromobacter eurydice isolated from soil, we clarified the pathway by which phenylpyruvate is metabolized to phenylacetate through phenylacetaldehyde. We defined the enzymes concerned as phenylpyruvate decarboxylase and phenylacetaldehyde dehydrogenase. Phenylpyruvate decarboxylase was purified and some of its properties were studied.
T, Asakawa, H, Wada, T, Yamano
openaire   +2 more sources

Phenylacetic acid excretion in man

Analytical Biochemistry, 1979
A rapid, reliable, sensitive, and highly specific mass fragmentographic method for the quantification of phenylacetic acid (PAA) in urine is described. The method was used to determine total, conjugated, and free PAA simultaneously in normal urine. The mean ± SE excretion of total, conjugated, and free PAA in urine of 24 normal adult volunteers were ...
M E, Martin, F, Karoum, R J, Wyatt
openaire   +2 more sources